Rachel Tsunemoto Hislop, PhD
Rachel Tsunemoto Hislop is a Principal in San Diego where she focuses on investments in innovative therapeutics and life science companies. Prior to joining Two Bear Capital, Rachel’s experiences in the therapeutic development process spanned from preclinical to post-approval. Most recently, Rachel was part of the Medical Affairs team at Acorda Therapeutics. Previously, she was a researcher on a California Institute of Regenerative Medicine grant in the laboratories of Dr. Lawrence Goldstein and Dr. Samuel Pfaff. Trained as a neuroscientist, Rachel earned her PhD from the University of California San Diego in Neuroscience where her work in the laboratory of Dr. Kristin Baldwin led to publications in Nature, Nature Neuroscience, and The EMBO Journal. She received her B.S. from Massachusetts Institute of Technology in Brain and Cognitive Sciences with a minor in Biomedical Engineering.
Contact Person For: